
On Monday, the American Bar Association (ABA) House of Delegates voted to oppose splitting the San Francisco-based 9th Circuit Court of Appeals. Instead, “technological and procedural innovations” should be used to efficiently handle the court’s large caseload.
President Donald Trump had criticized the 9th Circuit and called for its breakup, the Sacramento Bee reports. “I think that circuit is — that circuit is in chaos and that circuit is frankly in turmoil,” Trump said in February.
The president also gave an April interview saying, “There are many people that want to break up the Ninth Circuit. It’s outrageous.”
Trump’s opinion was not echoed on the floor of the House of Delegates, where no requests to speak in favor of splitting the court were made.
Instead, delegates Michael H. Reed of Pennsylvania and James Williams of the King County Bar Association spoke against splitting the 9th Circuit. Reed said that to accomplish the benefits predicted by a leading academic proponent of splitting the circuit, California would have to be split into two circuits, something that the academic conceded.
Williams said that there were three major reasons for the ABA to oppose the circuit split: Judges in the 9th Circuit don’t want it; lawyers in the 9th Circuit don’t want it; and businesses don’t want it.
Full Content: Law 360
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas